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The objective of the present study was to investigate the effects of the
direct addition of pentoxifylline (PF) to the ejaculates of men with
poor sperm quality before freezing on post-thaw sperm motility,
viability, acrosome integrity, and agonist-induced acrosome reaction.
Semen specimens from 16 infertile men with impaired sperm count
and motility (oligoasthenozoospermia) were divided into two equal
aliquots: one received no treatment (control) while the other was
incubated with 5 mM PF (treated). Both aliquots were cryopreserved
by the liquid nitrogen vapor method. Motility was assessed according
to WHO criteria. Acrosome integrity and spontaneous and calcium
ionophore-induced acrosome reactions were assessed with fluoresce-
in isothiocyanate-conjugated peanut agglutinin combined with a su-
pra-vital dye (Hoechst-33258). Cryopreservation impaired sperm
motility (percentage reduction: 87.4 (interquartile range, IQ: 70.3-
92.9) vs 89.1 (IQ: 72.7-96.0%)), viability (25.9 (IQ: 22.2-29.7) vs 25.6
(IQ: 19.7-40.3%)) and acrosome integrity (18.9 (IQ: 5.4-38.9) vs 26.8
(IQ: 0.0-45.2%)) to the same extent in both treated and control
aliquots. However, PF treatment before freezing improved the acro-
some reaction to ionophore challenge test scores in cryopreserved
spermatozoa (9.7 (IQ: 6.6-19.7) vs 4.8 (IQ: 0.5-6.8%); P = 0.002).
These data show that pre-freeze treatment of poor quality human
sperm with pentoxifylline did not improve post-thaw motility or
viability nor did it prevent acrosomal loss during the freeze-thaw
process. However, PF, as used, improved the ability of thawed sper-
matozoa to undergo the acrosome reaction in response to calcium
ionophore. The present data indicate that treatment of poor quality
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Introduction
Cryopreservation impairs sperm fertiliz-
ing ability by decreasing sperm motility and
motion characteristics, penetration into the
cervical mucus and into zona-free hamster
eggs, viability, membrane integrity and
acrosome structure, and activity of acro-
some protease and acrosin (1-4). Pentoxifyl-
line (PF), a phosphodiesterase inhibitor, has
been used to stimulate the motility and fertil-
izing capacity of human sperm (5-8). PF
inhibits cyclic adenosine monophosphate
(cAMP) phosphodiesterase, thus increasing
intracellular cAMP concentration (5,7) and
tyrosine-phosphorylation at the tail level (8).
cAMP has a role in sperm kinematics and in
the acrosome reaction second-messenger sys-
tem (7,9). Treatments that increase intracel-
lular cAMP concentrations often cause an
increase in sperm motility and kinematics as
well as in the agonist-induced acrosome re-
action (9) and fertilization rates (5,6). Also,
it has been postulated that PF has the ability
to scavenge reactive oxygen radicals (10,11).
It has been reported that pre-freeze sperm
treatment with PF decreases acrosome loss
during the freeze-thaw process and increases
the post-thaw agonist-induced acrosome re-
action rate in normal semen (12). This strat-
egy may be clinically useful because it can
improve the fertilizing potential of cryopre-
served human semen. One of the major ad-
vantages of sperm banking is the fertility
preservation in cancer patients prior to po-
tential gonadotoxic treatments, such as ra-
diotherapy and chemotherapy. Although
specimens of cancer patients freeze as effec-
tively as those from normal men, the semen
quality at the time of cryopreservation is
often poor in such individuals, especially in
testicular cancer patients (13). In the present
study, we investigated if the beneficial ef-
fects of the addition of PF directly to the
seminal plasma before freezing, as seen in
normal human semen (12), can also be dem-
onstrated in poor quality specimens, such as
those obtained from infertile men with de-




TEST yolk-buffer freezing medium,
sperm-washing medium (modified Biggers-
Whitten-Whittingam; BWW) and Dulbec-
co’s phosphate-buffered saline (PBS) were
purchased from Irvine Scientific (Santa Ana,
CA, USA). Fluorescein isothiocyanate-con-
jugated peanut agglutinin (FITC-PNA), cal-
cium ionophore A23187, PF, and bis-benzi-
mide (Hoechst-33258) were obtained from
Sigma (St. Louis, MO, USA).
A stock solution of FITC-PNA was pre-
pared by dissolving 2 mg FITC-PNA in 1
mL PBS and stored in 600-µL aliquots at
-20ºC. Hoechst-33258 was prepared by dis-
solving 1 mg H33258 in 1 mL PBS and
stored in 10-µL aliquots at -20ºC.
Semen collection, sperm processing and
cryopreservation procedures
Sperm specimens were obtained by mas-
turbation into sterile specimen cups from
men seeking infertility evaluation at a Uni-
versity-based hospital. All subjects were
asked to abstain from ejaculation from 2 to 3
days before collection. After liquefaction at
37ºC, a small aliquot was removed from
each specimen and the sperm parameters
were determined according to World Health
Organization (WHO) guidelines (14). A to-
tal of 16 oligoasthenozoospermic semen
samples were selected according to WHO
criteria for sperm count of <20 x 106/mL and
total motility of <50%. The etiology of male
infertility was not taken into consideration
in this study. The median values of sperm
count (million/mL), percent motility and
seminal plasma leukocytes, as assessed by
the Endtz test (14), were 12.0 (25-75% inter-
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quartile range: 9.0-14.0), 40.5 (25-75% in-
terquartile range: 30.0-59.0), and 0.2 (inter-
quartile range: 0.1-0.4), respectively. In-
formed consent from all subjects included in
the study and approval by the Institution
Ethics Committee were obtained. The ex-
perimental design and methods were identi-
cal to those reported in a previous study (12).
Briefly, after initial analysis each specimen
was divided into two equal aliquots. The
first aliquot received no treatment (control)
and the second was treated by adding a 10-
mM PF solution directly to the liquefied
ejaculate (1:1, v/v). The final concentration
of PF in the mixture was 5 mM. Control and
treated aliquots were incubated for 30 min at
37°C and then evaluated for percent and
progressive motility according to WHO cri-
teria (14), and for acrosome integrity (12,15).
Control and treated specimens were then
cryopreserved by the liquid nitrogen vapor
method (12). TEST-yolk buffer with glycer-
ol was used as a freezing agent for cryopre-
servation (15). Briefly, an aliquot of the
freezing medium equal to 25% of the origi-
nal specimen volume was added to the speci-
men. This process was repeated until the
ratio of freezing medium to ejaculate was
1:1. Cryovials were loaded with 1 mL freez-
ing medium/ejaculate mixture, and kept at
-20ºC for 8 min. Next, the cryovials were
exposed to liquid nitrogen vapor at -79ºC for
2 h before being plunged into liquid nitrogen
for storage at -196ºC. After at least 48 h in
liquid nitrogen, the samples were thawed at
room temperature for 5 min and transferred
to a 37ºC incubator for 20 min (4). In order to
remove the cryomedium, the thawed speci-
mens were diluted with BWW medium at a
ratio of 1 volume of freezing medium/ejacu-
late to 3 volumes of medium and washed by
centrifugation at 300 g for 7 min. The super-
natant was removed and the pellet resus-
pended in 0.7 mL BWW medium with 0.3%
human serum albumin. A small aliquot (0.1
mL) was removed from each washed speci-
men for the assessment of percent motility,
progressive motility and the frequency of
spontaneous acrosome reaction.
Sperm incubation under capacitating
conditions and ionophore challenge test
After thawing, the motile sperm popula-
tion from each specimen was isolated by the
swim-up method from a washed sperm prepa-
ration (15). The motile spermatozoa were
then capacitated for 3 h by incubation in
BWW medium with 3% human serum albu-
min at 37ºC in a 5% CO2 atmosphere (4).
After capacitation the specimens were di-
vided into two equal aliquots: one was incu-
bated with 2.5 µmol/L calcium ionophore
A23187 solution, and the other was treated
with dimethylsulfoxide (10%, v/v) solution
to serve as a control (12). Both aliquots were
then incubated at 37ºC for 1 h under the
same experimental conditions.
Assessment of viability, acrosome status and
ionophore-induced acrosome reaction
Acrosome status was assessed with FITC-
PNA in combination with the nuclear stain
bis-benzimide to monitor viability. Viability
and acrosome status were assessed simulta-
neously by mixing 100 µL of sperm speci-
mens with 100 µL of a 2-µg/mL Hoechst-
33258 solution (12). The mixture was incu-
bated for 10 min in the dark. Excess stain
was removed from the spermatozoa by dilu-
tion with PBS and centrifugation at 300 g for
5 min, and the pellet was resuspended in 100
µL BWW. A 20-µL aliquot of this solution
was smeared on a microscope slide and al-
lowed to dry in the dark at room tempera-
ture. Air-dried slides were immersed in ice-
cold methanol for 30 s to permeabilize the
sperm membranes. The fixed smears were
immersed in a solution of 40 µg/mL FITC-
PNA for 20 min, and washed gently in PBS
to remove excess label.
A fluorescence microscope (Eclipse
E600, Nikon, Tokyo, Japan) equipped with
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an epi-illumination module and a mercury
ultraviolet source was used to examine the
slides at 1000X magnification. The B2A
filter cube was used for FITC-PNA, which
fluoresces apple-green, and the UV2A cube
for Hoechst-33258, which fluoresces a bright
medium blue. Hoechst-33258 stains the nu-
clei of damaged cells (dead spermatozoa),
which show a bright blue-white fluorescence,
and is excluded from viable cells (live sper-
matozoa), which show a pale blue fluores-
cence. The same spermatozoon was exam-
ined for FITC-PNA labeling and for Hoechst-
33258 staining by interchanging the two
filters (12).
Staining patterns showing sperm viability and
acrosome status
In viable spermatozoa, the sperm head
showed a pale-blue fluorescence, and in dead
spermatozoa, the sperm head showed a bright
blue-white fluorescence. In an intact acro-
some, the acrosomal region of the sperm
head exhibited a uniform apple-green fluo-
rescence, and in a reacted acrosome, only
the equatorial segment of the acrosome was
stained. A total of 200 spermatozoa per sam-
ple were scored. The calculated frequency
of spermatozoa with intact and reacted
acrosomes was based on viable cells only.
The acrosome reaction to ionophore chal-
lenge (ARIC) scores was calculated by sub-
tracting the frequency of acrosome reaction
occurrence following ionophore challenge
from the frequency of occurrence before it.
Statistical analysis
On the basis of previously published data
showing that the average percent decrease in
sperm motility, viability and acrosome in-
tegrity after the freeze-thawing process is
about 15% (2,4,12,13,15,16), and that in
vitro sperm treatment with PF increases
sperm motility and acrosome response to
ionophore challenge from 10 to 20% (12,17,
18), we expected that similar results would
be achieved with the experimental condi-
tions used in the present study. Assuming a
level of significance of 0.05 and a power of
80%, it was calculated that 15 subjects were
needed in each experimental group to detect
differences of ≥10% in the main outcome
measures (sperm motility, viability, acro-
some integrity, and acrosome reaction in
response to ionophore challenge). Data were
assessed for homogeneity and normality by
the Kolgomorov-Smirnov test. Statistical
differences in sperm motility, viability and
acrosome status between control and treated
specimens before or after cryopreservation
were assessed by the Wilcoxon signed-rank
test. Data are reported as median and inter-
quartile range. The level of significance was
set at P < 0.05. Statistical analysis was per-
formed using the SAS statistical software
package (Cary, NC, USA).
Results
Pre-freeze and post-thaw sperm motility
and viability in control and PF-treated speci-
mens are compared in Table 1. Before freez-
ing, PF treatment significantly increased both
the percentage of motile spermatozoa (P <
0.01) and the percentage of spermatozoa
exhibiting progressive motility (P = 0.006).
However, PF treatment did not alter pre-
freeze sperm viability. The freeze-thaw pro-
cess significantly decreased sperm motility
(P < 0.001), progressive motility (P < 0.001)
and viability (P < 0.001) in both control and
treated specimens. The percent change in
these parameters from before freezing to
after thawing was not statistically different
between treated and non-treated groups.
Percentages of viable spermatozoa with
intact acrosomes in control and PF groups
before and after cryopreservation are shown
in Table 1. Acrosome integrity did not differ
between control and treated groups before
freezing. The freeze-thaw process signifi-
cantly decreased the percentages of live
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sperm with intact acrosomes in both the
control and PF groups (P < 0.001; Table 1).
The percentage of spermatozoa that lost
acrosomal contents during freezing and thaw-
ing, assessed by subtracting the percentage
of viable-intact acrosome spermatozoa post-
thaw from the pre-freezing percentage, was
18.9 and 26.8% in the control and PF groups,
respectively (Table 1). However, the differ-
ences were not statistically significant.
The effects of calcium ionophore on the
acrosome status of thawed viable spermato-
zoa of the control and PF groups are shown
in Table 2. After thawing, the percentage of
live spermatozoa exhibiting a spontaneous
acrosome reaction in control and treated
specimens was 43.9 and 38.0%, respectively
(Table 2). Again the differences were not
statistically significant.
The ARIC was calculated by subtracting
the frequency of acrosome reaction occur-
rence after ionophore challenge from the
frequency of occurrence before it. ARIC
scores were significantly increased in both
the control (P = 0.02) and PF groups (P <
0.001). However, ARIC scores were signifi-
cantly higher in the PF-treated group (me-
dian: 9.7% (25-75% interquartile range: 6.6-
19.7)) than in control (median: 4.8% (25-
75% interquartile range: 0.5-6.8; P = 0.002)).
We observed that ARIC scores were
higher than 10% in 50% (8 of 16) of the
specimens in the PF group. In the remaining
specimens, ARIC scores were between 5
and 10% in 6 (6/8), and <5% in only 2
specimens (Figure 1). In the control group,
only 19% (3 of 16) of the specimens had
ARIC scores >10%. In the remaining 13
specimens, five exhibited ARIC scores be-
tween 5 and 10%, and 8 scores <5%. When
an individual specimen was compared to its
own control, pre-freeze PF treatment was
found to improve the ARIC scores in 81.2%
of the specimens (13/16; Figure 1). Interest-
ingly, pre-freeze PF treatment improved
ARIC scores to >10% in all but 1 (4/5)
control specimens with scores between 5
Table 1. Effect of pre-freeze treatment with pentoxifylline on motility, viability and
acrosome integrity of sperm from 16 oligoasthenozoospermic men before and after
cryopreservation.
Sperm parameters Control Pentoxifylline
Percent motility
Pre-freeze 40.5 (30.0-59.0) 55.5 (41.5-62.5)*
Post-thaw 3.5 (2.5-10.5) 5.0 (2.5-12.0)
Percent changea 87.4 (70.3-92.9) 89.1 (72.7-96.0)
P valueb <0.001 <0.001
Progressive motility (%grades a + b)
Pre-freeze 35.5 (24.0-58.0) 47.0 (34.5-59.5)*
Post-thaw 1.5 (0.0-5.0) 2.0 (0.0-6.0)
Percent changea 94.5 (74.1-99.9) 94.4 (84.1-100.0)
P valueb <0.001 <0.001
Sperm viability (%)
Pre-freeze 76.2 (73.0-90.0) 74.6 (70.6-92.1)
Post-thaw 54.6 (48.0-61.2) 50.7 (44.7-59.2)
Percent changea 25.9 (22.2-29.7) 25.6 (19.7-40.3)
P valueb <0.001 <0.001
Acrosome integrity (%)
Pre-freeze 79.2 (67.7-82.7) 76.2 (73.2-81.5)
Post-thaw 62.8 (52.9-80.2) 58.0 (45.9-71.2)
Percent changea 18.9 (5.4-38.9) 26.8 (0.0-45.2)
P valueb <0.001 <0.001
Data are reported as median with interquartile range in parentheses. Progressive
motility = grade a (spermatozoa exhibiting fast progression) and grade b (spermato-
zoa exhibiting slow progression) according to WHO criteria.
aPercent change calculated as median of individual changes; bP value comparing pre-
freeze to post-thaw (Wilcoxon signed-rank test). *P < 0.05 compared to control
(Wilcoxon signed-rank test).
Table 2. Effects of pre-freeze treatment with pentoxifylline on post-thaw calcium
ionophore-induced acrosome reaction in sperm from 16 oligoasthenozoospermic
men.
Post-thaw frequency of live Control Pentoxifylline
spermatozoa with reacted
acrosomes (%)
Before ionophore challenge 43.9 (27.2-54.5) 38.0 (30.1-51.2)
After ionophore challenge 45.6 (25.7-59.1) 52.7 (38.5-67.4)*
Percent changea -11.8 (-(32.0-2.9)) -30.2 (-(40.8-18.5))*
ARIC score (%)* 4.8 (0.5-6.8) 9.7 (6.6-19.7)
P valueb <0.001 <0.001
Data are reported as median with interquartile range in parentheses. Acrosome
reaction in response to ionophore challenge (ARIC) score was calculated by subtract-
ing the frequency of acrosome reaction occurrence after ionophore challenge from the
frequency of occurrence before it.
aPercent change calculated as median of individual changes; bP value comparing
frequency of live spermatozoa with reacted acrosomes before and after ionophore
challenge (Wilcoxon signed-rank test). *P < 0.05 compared to control (Wilcoxon
signed-rank test).
990
Braz J Med Biol Res 40(7) 2007
S.C. Esteves et al.
www.bjournal.com.br
and 10%. Similarly, pre-freeze PF treatment
improved ARIC scores to >5% in all but 1
(7/8) control specimens with scores <5%.
Only 3 specimens were refractive to PF treat-
ment (Figure 1).
Discussion
At a concentration of 5 mM PF has oxy-
gen-free radical scavenging capacities by
reducing the superoxide release from human
spermatozoa following phorbol myristate
acetate (11). Higher PF concentrations, how-
ever, may be detrimental to membrane in-
tegrity (19). Normal sperm incubated with 5
mM PF prior to cryopreservation are pro-
tected from the deleterious effects of the
freeze-thaw process (12). Based on these
findings, PF may be used as a supplement to
the cryomedia currently available. In this
study, we examined if the benefits of PF for
freezing normal sperm can be extrapolated
to poor quality sperm obtained from oligoas-
thenozoospermic men. Oligoasthenozo-
ospermia is often seen in cancer patients,
who are the main patient population seeking
sperm banking. Our results indicated that
the cryopreservation process was detrimen-
tal to sperm motility and viability, irrespec-
tive of whether or not spermatozoa had been
treated with PF before freezing, corroborat-
ing previous reports (12). Others have dem-
onstrated an enhancement in post-thaw sperm
motility when PF was added prior to cryo-
preservation (17,18). It is possible that at the
concentration used in our study, post-thaw
spermatozoa were unable to respond effec-
tively to PF in terms of motility, either be-
cause of membrane damage caused by cryo-
preservation, or because they may be sensi-
tized and require different concentrations
for stimulation. Moreover, we observed a
significant decrease in the post-thaw per-
centage of viable spermatozoa with intact
acrosomes in both control and PF-treated
specimens. In normal semen, a PF-induced
protective effect on acrosome loss during
the freeze-thaw process was observed (12).
In the present study, we evaluated poor qual-
ity semen, and it is possible that normal
semen would resist cryoinjury better than
semen obtained from oligoasthenozoosper-
mic men. We observed that prefreeze treat-
ment of sperm from such individuals with
PF improved the ability of cryo-thawed sper-
matozoa to undergo the acrosome reaction
in response to stimuli. Interestingly, the abil-
ity of cryo-thawed sperm from abnormal
specimens to respond to ionophore chal-
lenge appears to be lower than that of normal
sperm, irrespectively of treatment with PF
before freezing (12). In our study, post-thaw
acrosome reaction stimulated by calcium
ionophore was 11.8 and 30.2% for control
and treated specimens, respectively, while
values of 34.8 and 53.3% have been re-
ported for normal men (12). A possible ex-
planation for these differences is that PF, as
used, may afford cryoprotection in normal
semen while a different concentration is nec-
essary to neutralize excessive reactive oxy-
gen species (ROS) emanating from the al-
ready compromised spermatozoa from oli-
goasthenozoospermic individuals. To our
Figure 1. Effects of pre-freeze pentoxifylline treatment on post-thaw acrosome reaction to
ionophore challenge (ARIC) in sperm from 16 oligoasthenozoospermic men. Bars represent
ARIC scores for each individual: control (filled bars) and 5 mM pentoxifylline-treated (open
bars). Filled bars are not seen in controls 1, 4, and 9 because ARIC scores were equal to
zero (post-thaw live spermatozoa in these specimens were refractive to stimulation with
calcium ionophore).
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knowledge, this is the first study to suggest
that the benefits of using PF for freezing
human sperm may be related to sperm qual-
ity.
Although we did not examine ROS lev-
els in the seminal plasma, it has been shown
that ROS levels are significantly higher, and
seminal plasma antioxidant capacity is sig-
nificantly reduced in poor quality sperm,
independent of the clinical diagnosis of male
infertility (20). We speculate that cryopre-
served spermatozoa from men with defec-
tive spermatogenesis may have higher levels
of ROS than those from normal men. Conse-
quently, peroxidation of unsaturated fatty
acids in the acrosomal membranes may be
more extended, thus decreasing the response
to calcium influx signals that trigger the
acrosome reaction.
Sperm function tests such as the acro-
some reaction are better fertility predictors
than traditional semen parameters (21-28).
The mechanism of the acrosome reaction
induced by ionophores differs from the physi-
ological acrosome reaction induced by the
zona pellucida (22). While the physiological
acrosome reaction involves activation of sev-
eral signal transduction pathways, the iono-
phore-induced acrosome reaction mainly
involves a chemical effect on calcium influx
that partially reflects the physiological acro-
some reaction process (22). We did not test
other physiological agonists on the acro-
some reaction, such as progesterone or re-
combinant zona pellucida. Instead, we elected
to use the ionophore-induced acrosome re-
action because it has been extensively vali-
dated as a sperm function test with excellent
predictive values for outcomes in assisted
reproduction (23-28). Using an ARIC cutoff
of 10%, the sensitivity of the test in predict-
ing subfertility was 54%, with a positive
predictive value of 64% and specificity of
85% (24-26). In the present study, ARIC
scores were higher than 10% in 50% of the
cryopreserved PF-treated specimens, and in
only 19% of the controls. In normal men,
ARIC scores higher than 10% were seen in
80 and 60% of the cryo-thawed PF-treated
and control specimens, respectively (12).
We observed that PF improved ARIC scores
in 81.2% of our subjects, whereas improve-
ment in all individuals was seen in normal
semen (12).
We have shown that pre-freeze treatment
of poor quality human sperm with PF im-
proved the ability of thawed spermatozoa to
undergo the acrosome reaction in response
to calcium ionophore. Further investigation
is needed to determine whether treatment of
poor quality human sperm with PF before
freezing improves fertilization and pregnancy
outcomes in assisted reproduction.
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